BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 15982216)

  • 21. Characteristic Cytological Findings of Lobular Endocervical Glandular Hyperplasia Associated with Adenocarcinoma of the Uterine Cervix.
    Ishii S; Ito T; Yamada M; Yamazaki N; Ikebata K; Fujiyama J; Furuta N; Komatsu K; Takeuchi K; Sugiyama Y; Takazawa Y
    Acta Cytol; 2020; 64(6):556-562. PubMed ID: 32814324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions.
    Liang J; Mittal KR; Wei JJ; Yee H; Chiriboga L; Shukla P
    Int J Gynecol Pathol; 2007 Jan; 26(1):71-5. PubMed ID: 17197900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glandular cell atypia on Papanicolaou smears: interobserver variability in the diagnosis and prediction of cell of origin.
    Simsir A; Hwang S; Cangiarella J; Elgert P; Levine P; Sheffield MV; Roberson J; Talley L; Chhieng DC
    Cancer; 2003 Dec; 99(6):323-30. PubMed ID: 14681938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffuse laminar endocervical glandular hyperplasia. A benign lesion often confused with adenoma malignum (minimal deviation adenocarcinoma).
    Jones MA; Young RH; Scully RE
    Am J Surg Pathol; 1991 Dec; 15(12):1123-9. PubMed ID: 1746679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lobular endocervical glandular hyperplasia might become a precursor of adenocarcinoma with pyloric gland features.
    Ohta Y; Suzuki T; Hamatani S; Shiokawa A; Kushima M; Ota H
    Pathol Res Pract; 2008; 204(9):683-7. PubMed ID: 18462891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'.
    Mikami Y; Kiyokawa T; Hata S; Fujiwara K; Moriya T; Sasano H; Manabe T; Akahira J; Ito K; Tase T; Yaegashi N; Sato I; Tateno H; Naganuma H
    Mod Pathol; 2004 Aug; 17(8):962-72. PubMed ID: 15143335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
    Asaka S; Nakajima T; Momose M; Miyamoto T; Uehara T; Ota H
    Virchows Arch; 2019 Jan; 474(1):79-86. PubMed ID: 30324235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix.
    Jaworski RC
    Semin Diagn Pathol; 1990 Aug; 7(3):190-204. PubMed ID: 2171126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic significance of endocervical glandular cells with "golden-yellow" mucin on pap smear.
    Hata S; Mikami Y; Manabe T
    Diagn Cytopathol; 2002 Aug; 27(2):80-4. PubMed ID: 12203873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glandular lesions of the uterine cervix.
    Zaino RJ
    Mod Pathol; 2000 Mar; 13(3):261-74. PubMed ID: 10757337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uterine cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia: Radiologic-pathologic correlation.
    Ohya A; Asaka S; Fujinaga Y; Kadoya M
    J Obstet Gynaecol Res; 2018 Feb; 44(2):312-322. PubMed ID: 29144012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the insulin-like growth factor-II mRNA-binding protein 3 (IMP3) and carcinoembryonic antigen (CEA) in mucinous minimal deviation adenocarcinoma.
    He Y; Li L; Jiang W; Wang DQ; Xu L; Huang Q; Zhang Y; Yang KX
    Pathol Res Pract; 2011 May; 207(5):295-9. PubMed ID: 21497449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biology and management of lobular endocervical glandular hyperplasia.
    Miyamoto T; Kobara H; Shiozawa T
    J Obstet Gynaecol Res; 2022 Dec; 48(12):3056-3067. PubMed ID: 36177810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The developing spectrum of gastric-type cervical glandular lesions.
    Talia KL; McCluggage WG
    Pathology; 2018 Feb; 50(2):122-133. PubMed ID: 29233547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p16INK4a overexpression independent of human papillomavirus infection in lobular endocervical glandular hyperplasia.
    Hashi A; Xu JY; Kondo T; Hashi K; Yuminamochi T; Nara M; Murata S; Katoh R; Hoshi K
    Int J Gynecol Pathol; 2006 Apr; 25(2):187-94. PubMed ID: 16633071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gross features of lobular endocervical glandular hyperplasia in comparison with minimal-deviation adenocarcinoma and stage Ib endocervical-type mucinous adenocarcinoma of the uterine cervix.
    Sasajima Y; Mikami Y; Kaku T; Kiyokawa T; Ohishi Y; Hamada T; Sasaki T; Fujita H; Moriya T; Kasamatsu T; Tsuda H
    Histopathology; 2008 Oct; 53(4):487-90. PubMed ID: 18631191
    [No Abstract]   [Full Text] [Related]  

  • 37. Adenomyomas of the uterine cervix of of endocervical type: a report of ten cases of a benign cervical tumor that may be confused with adenoma malignum [corrected].
    Gilks CB; Young RH; Clement PB; Hart WR; Scully RE
    Mod Pathol; 1996 Mar; 9(3):220-4. PubMed ID: 8685218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of gastric-type adenocarcinoma of the uterine cervix associated with lobular endocervical glandular hyperplasia: radiologic-pathologic correlation.
    Tsuboyama T; Yamamoto K; Nakai G; Yamada T; Fujiwara S; Terai Y; Ohmichi M; Narumi Y
    Abdom Imaging; 2015 Mar; 40(3):459-65. PubMed ID: 25504516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Image quantification technology of the heterochromatin and euchromatin region for differential diagnosis in the lobular endocervical glandular hyperplasia.
    Kimura F; Kobayashi T; Kanai R; Kobayashi Y; Yuhi O; Ota H; Yamaguchi M; Yokokawa Y; Uehara T; Ishii K
    Diagn Cytopathol; 2019 Jun; 47(6):553-563. PubMed ID: 30761780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunophenotype analysis using CLDN18, CDH17, and PAX8 for the subcategorization of endocervical adenocarcinomas in situ: gastric-type, intestinal-type, gastrointestinal-type, and Müllerian-type.
    Asaka S; Nakajima T; Kugo K; Kashiwagi R; Yazaki N; Miyamoto T; Uehara T; Ota H
    Virchows Arch; 2020 Apr; 476(4):499-510. PubMed ID: 31932920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.